Scientific Publication

Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar

author(s) Thi, A.M.. - Shewade, H.D.. - Kyaw, N.T.T. - Oo, M.M.. - Aung, T.K..
from UK Foreign, Commonwealth & Development Office (FCDO)
permalink open
themes
regions
  • Northern Europe
  • Europe
  • World
  • South-Eastern Asia
  • Asia
citation

Thi, A. M.; Shewade, H. D.; Kyaw, N. T. T.; Oo, M. M. Aung, T. K.; Aung, S. T.; Oo, H. N.; Win, T.; Harries, A. D. Source: Public Health Action, Volume 6, Number 2, 21 June 2016, pp. 111-117(7) International Union Against Tuberculosis and Lung Disease DOI: https://doi.org/10.5588/pha.16.0009

Publications and datasets provided via GARDIAN

Abstract

Determines time to starting antiretroviral treatment (ART) in relation to anti-tuberculosis treatment (ATT) This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Open original